Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (12): 766-766.
Previous Articles Next Articles
CHEN Congqin1, CHEN Zhiqiang1, CHEN Chunmei1, ZHANG Qiang2*
Received:2019-01-18
Revised:2019-01-18
Online:2018-12-20
Published:2019-01-18
CLC Number:
CHEN Congqin, CHEN Zhiqiang, CHEN Chunmei, ZHANG Qiang. One Case of Hallucination Induced by Levofloxacin Sodium Chloride Injection Combined with Nimesulide Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 766-766.
Add to citation manager EndNote|Ris|BibTeX
| [1] 谢红莲. 滴速与盐酸左氧氟沙星注射液不良反应发生关系的探讨[J]. 医学理论与实践, 2012, 25(13):1637-1639. [2] 段小军, 谈平, 李艳娟. 左氧氟沙星注射液致血液透析患者精神异常1 例[J]. 中国药物警戒, 2016, 13(10):632-633. [3] 钟晗, 刘晓琰, 崔敏, 等. 155例喹诺酮类药品不良反应分析[J]. 中国药物警戒, 2016, 10(5):309-311. [4] 李焕芬, 胡月琴. 莫西沙星致眩晕与视物模糊[J]. 药物不良反应杂志, 2016, 18(2):149-150. [5] 张巍巍, 许琳, 耿长新, 等. 左氧氟沙星诱发分离(转换)性障碍[J]. 药物不良反应杂志, 2011, 13(6):379-380. [6] 单爱莲, 赵桂元, 钱思源. 左氧氟沙星不良反应的国内外文献个案调查与分析[J]. 中国临床药理学杂志, 2012, 28(3):212-217. [7] 管枚, 金朝辉, 杨娟. 282例左氧氟沙星不良反应报告分析[J]. 中国药物警戒, 2007, 4(3):158-161. [8] 梁雁, 鲁云兰. 左氧氟沙星注射液不良反应及相关因素[J]. 药物不良反应杂志, 2003,5(2):77-80. [9] Katsuro Yagawa.Latest industry information on the safety profile of levofloxacin in Japan[J]. Chemotherapy, 2001, 47(suppl 3):38. [10] 陈晓萌, 张梦, 刘凌燕. 调整1例出现药物不良反应患者治疗方案的分析[J]. 中国医药科学, 2014, 4(20):85-90. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
